Hol EM - Search Results

1

Mutations in RNA: a first example of molecular misreading in Alzheimer's disease.

van Leeuwen FW, Burbach JP, Hol EM. van Leeuwen FW, et al. Among authors: hol em. Trends Neurosci. 1998 Aug;21(8):331-5. doi: 10.1016/s0166-2236(98)01280-6. Trends Neurosci. 1998. PMID: 9720597 Review.

2

Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients.

van Leeuwen FW, de Kleijn DP, van den Hurk HH, Neubauer A, Sonnemans MA, Sluijs JA, Köycü S, Ramdjielal RD, Salehi A, Martens GJ, Grosveld FG, Peter J, Burbach H, Hol EM. van Leeuwen FW, et al. Among authors: hol em. Science. 1998 Jan 9;279(5348):242-7. doi: 10.1126/science.279.5348.242. Science. 1998. PMID: 9422699

3

Dinucleotide deletions in neuronal transcripts: a novel type of mutation in non-familial Alzheimer's disease and Down syndrome patients.

Hol EM, Neubauer A, de Kleijn DP, Sluijs JA, Ramdjielal RD, Sonnemans MA, van Leeuwen FW. Hol EM, et al. Prog Brain Res. 1998;117:379-95. doi: 10.1016/s0079-6123(08)64028-5. Prog Brain Res. 1998. PMID: 9932421 No abstract available.

4

Molecular misreading of genes in Down syndrome as a model for the Alzheimer type of neurodegeneration.

van Leeuwen FW, Hol EM. van Leeuwen FW, et al. Among authors: hol em. J Neural Transm Suppl. 1999;57:137-59. doi: 10.1007/978-3-7091-6380-1_9. J Neural Transm Suppl. 1999. PMID: 10666673 Review.

5

Molecular misreading. A new type of transcript mutation in gerontology.

van Leeuwen FW, Fischer DF, Benne R, Hol EM. van Leeuwen FW, et al. Among authors: hol em. Ann N Y Acad Sci. 2000 Jun;908:267-81. doi: 10.1111/j.1749-6632.2000.tb06654.x. Ann N Y Acad Sci. 2000. PMID: 10911966

6

Molecular misreading in non-neuronal cells.

Van Leeuwen FW, Hol EM, Hermanussen RW, Sonnemans MA, Moraal E, Fischer DF, Evans DA, Chooi KF, Burbach JP, Murphy D. Van Leeuwen FW, et al. Among authors: hol em. FASEB J. 2000 Aug;14(11):1595-602. doi: 10.1096/fj.14.11.1595. FASEB J. 2000. PMID: 10928994

7

Molecular misreading: a new type of transcript mutation expressed during aging.

van Leeuwen FW, Fischer DF, Kamel D, Sluijs JA, Sonnemans MA, Benne R, Swaab DF, Salehi A, Hol EM. van Leeuwen FW, et al. Among authors: hol em. Neurobiol Aging. 2000 Nov-Dec;21(6):879-91. doi: 10.1016/s0197-4580(00)00151-2. Neurobiol Aging. 2000. PMID: 11124436 Review.

8

Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death.

De Vrij FM, Sluijs JA, Gregori L, Fischer DF, Hermens WT, Goldgaber D, Verhaagen J, Van Leeuwen FW, Hol EM. De Vrij FM, et al. Among authors: hol em. FASEB J. 2001 Dec;15(14):2680-8. doi: 10.1096/fj.01-0438com. FASEB J. 2001. PMID: 11726544

9

+1 Proteins and aging.

van Leeuwen FW, Gerez L, Benne R, Hol EM. van Leeuwen FW, et al. Among authors: hol em. Int J Biochem Cell Biol. 2002 Nov;34(11):1502-5. doi: 10.1016/s1357-2725(02)00043-2. Int J Biochem Cell Biol. 2002. PMID: 12200043 Review.

10

Frameshifted beta-amyloid precursor protein (APP+1) is a secretory protein, and the level of APP+1 in cerebrospinal fluid is linked to Alzheimer pathology.

Hol EM, van Dijk R, Gerez L, Sluijs JA, Hobo B, Tonk MT, de Haan A, Kamphorst W, Fischer DF, Benne R, van Leeuwen FW. Hol EM, et al. J Biol Chem. 2003 Oct 10;278(41):39637-43. doi: 10.1074/jbc.M302295200. Epub 2003 Aug 4. J Biol Chem. 2003. PMID: 12900421

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results